UTI · Earnings event · Q2 2026 · archived
Universal Technical Institute I (UTI) Q2 2026 earnings — TrendMatrix coverage
Reported · EPS $0.04 vs estimate $0.02 (+118.2%) — classified BEAT.
Model-generated analysis — not investment advice. Not a registered investment advisor. Past performance does not guarantee future results. How we score · Full disclosure
Event detail · Q2 2026
EPS beat/miss and revenue
| Metric | Estimate | Actual | Surprise |
|---|---|---|---|
| EPS (diluted) | $0.02 | $0.04 | +118.2% |
| Revenue | — | — | — |
Verdict reaction
How the verdict moved around this report
Before this report, TrendMatrix rated UTI Buy (Wait) at 4.4/10. After the Q2 2026 report, the verdict moved to Sell at 4.5/10.
Consumer Defensive context
UTI at TrendMatrix's latest read
Defensive staples are judged on margin resilience: pricing power against input costs matters more here than top-line drama.
- Industry
- Education & Training Services
- Market cap
- $1.39B
- P/E (fwd)
- 27.0
- P/E (ttm)
- 41.2
- 52-week range
- $21.29–$51.34
- Off 52-week high
- 51.0%
- RSI (14)
- 26
- Volume vs avg
- 1.11×
- Engine score
- 4.4/10
Live context at TrendMatrix’s latest engine read — updates after the report date; not frozen to it.